
Much-hyped Alzheimer’s drugs do not help patients, review finds
A major Cochrane review finds Alzheimer’s drugs like lecanemab and donanemab do not deliver meaningful clinical benefits, raising fresh debate over…
· 2 MIN READ
Topic
Latest Daily Tribune news and analysis on Alois Alzheimer.